• Skip to primary navigation
  • Skip to main content
Engineered Tissue Solutions

Engineered Tissue Solutions

  • Chronic Wound Care
    • Mirragen
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Surgical Wound Care
    • MirraSurg
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Science & Technology
  • Provider & Patient Support
    • For Providers
    • For Patients
    • Reimbursement
  • About
    • Contact Us
    • News & Events
    • Careers
    • Testimonials
  • Request Information

Case Study: Surgical Dehiscence – Trans Metatarsal Amputation


Patient History

  • Wound dehiscence
  • Soft tissue skin necrosis
  • Diabetic
  • Neuropathy
  • Prior failed treatments
    • 3 surgical closures
    • 2 skin substitutes
    • 1 amnion graft

Treatment

  • Debridement of wound and necrotic soft tissue
  • MirragenĀ® application weekly x 5 weeks
  • No additional debridement required
  • Wound fully closed in 42 days
Day 1 – 7 cm x 3 cm
Day 42 – Closed

Learn how ETS is transforming wound care.

Access Literature
  • Request Information
  • Contact Us
  • Careers
  • LinkedIn
  • Facebook
  • Instagram
  • Disclaimer
  • Privacy
  • Terms & Conditions
  • Patents

MIRRAGEN® is a registered trademark of ETS Tech Holdings, LLC. | © ETS Wound Care